The Fifth Annual Retina Fellow Summit
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Overview
Activity Release Date: 12/31/2020
Activity Expiration Date: 12/31/2021
Activity Overview
This activity features highlights captured from the Fifth Annual Retina Fellow Summit held in November 2020. The Summit included an expert faculty panel and an audience of retina fellows engaging in discussions on current clinical data, clinical cases, and practice transitions.
The overall goal of this program is to provide retina fellows, ophthalmology residents, retina specialists, and comprehensive ophthalmologists who treat diseases of the retina with cutting-edge clinical data, translational research, and practice information to optimize patient care and facilitate practice transitions.
Provider Statement
This activity is jointly provided by AKH, Inc., Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC.
Support Statement
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Target Audience
Retina fellows and ophthalmology residents (primary)
Retina specialists and comprehensive ophthalmologists who treat diseases of the retina (secondary)
Learning Objectives
After participating in this activity, participants will demonstrate the ability to:
- Evaluate and interpret the continually expanding literature on the treatment of retinal vascular diseases
- Develop optimal, individualized management plans for patients with retinal vascular diseases by applying the latest clinical data
- Describe considerations for effectively transitioning from residency/fellowship to practice
- Discuss practical aspects for achieving success in various practice settings
Faculty
Quan Dong Nguyen, MD, MSc, FAAO
(Course co-director)
Professor of Ophthalmology
Byers Eye Institute
Stanford University School of Medicine
Palo Alto, California
Diana V. Do, MD, FAAO
(Course co-director)
Professor of Ophthalmology
Byers Eye Institute
Stanford University School of Medicine
Palo Alto, California
Peter A. Campochiaro, MD
Professor of Ophthalmology and Neuroscienes
Wilmer Eye Institute
Johns Hopkins University School of Medicine
Baltimore, Maryland
Peter K. Kaiser, MD
Professor of Ophthalmology
Chair, Ophthalmology Research
Cole Eye Institute
Cleveland Clinic Foundation
Cleveland, Ohio
Jonathan L. Prenner, MD
Clinical Professor and Chairman
Department of Ophthalmology
Rutgers, Robert Wood Johnson Medical School
New Brunswick, New Jersey
Christina Y. Weng, MD, MBA
Associate Professor of Ophthalmology
Vitreoretinal Diseases & Surgery Fellowship Program Director
Baylor College of Medicine
Houston, Texas
Reviewers
Louis Settembrino, CHCP, Catalyst Medical Education, LLC, President and CEO
Dorothy Caputo, MA, BSN, RN, AKH Lead Nurse Planner/Reviewer
Patricia Brignoni, AKH Director of Operations/Reviewer
Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designatoin
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
How to Participate in this Activity and Obtain CME Credit
Statements of credit will be awarded based on the participant reviewing activity, scoring a 70% or higher on the post test, and completing and submitting an activity evaluation. A statement of credit will be available upon completion of an online evaluation/claimed credit form. You must participate in the entire activity to receive credit. There is no fee to participant in this activity.
Disclosures
It is the policy of AKH, Inc., Advancing Knowledge in Healthcare to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH, Inc., Advancing Knowledge in Healthcare, prior to accreditation of the activity and may include any of, or combination of, the following: attestation to non-commercial content, notification of independent and certified CME expectations, referral to National Faculty Initiative training, restriction of topic area or content, restriction to discussion of science only, amendment of content to eliminate discussion of device or technique, use of other faculty for discussion of recommendations, independent review against criteria ensuring evidence support recommendation, moderator review, and peer review. AKH, Inc., Advancing Knowledge in Healthcare planners and reviewers have no relevant financial relationships to disclose.
Faculty reports the following relationship(s)
Peter Campochiaro, MD, has disclosed the following relevant financial relationships:
Consultant - Aerpio Pharmaceuticals, Allegro, Applied Genetic Technologies Corporation, Asclepix Therapeutics, Ashvattha Therapeutics, Baucsh and Lomb, Clearside, Curevac, Exonate LTD, Genentech/Roche Inc, Graybug Vision, Merck & Co, Inc, Perfuse, Regeneron Pharmaceuticals, Inc, Wave Life Sciences
Contracted Research - Aerpio Pharmaceuticals, Asclepix Therapeutics, Ashvattha Therapeutics, Genentech/Roche Inc, MallincKrodt Pharmaceuticals, Genzyme, Oxford Biomedica, Regenxbio, Inc.
Stock - Allegro, Graybug
Diana Do, MD has disclosed the following relevant financial relationships:
Consultant - Regeneron, Genentech, Boehringer Ingelheim, Mallinkrodt, Novartis, Asclepix
Contracted Research - Regeneron, Boehringer Ingelheim, Novartis, Asclepix
Stock - Kodiak Sciences
Peter Kaiser, MD, has disclosed the following relevant financial relationships:
Consultant - Aerie, Alcon, Allegro, Allergan, Alzheon, Annexon Biosciences, AsclepiX, Bayer, Bausch and Lomb, Biogen Idec, Bionic Vision Technologies, Boerenger Ingelheim, Carl Zeiss Meditec, Clearside Biomedical, DTx Pharma, Duet Therapeutics, Eyevensys, Formycon/BioEq GmbH, Galecto Biotech, Galimedix, Gemini Therapeutics, Glaukos, Innovent, iRenix, iVericBio, jCyte, Kanaph Therapeutics, Kanghong, Kodiak, NGM Biopharmaceuticals, Inc., Novartis , Ocugenix, Oculis, Ocuphire, OcuTerra Therapeutics Inc., Omeros, Opthea, Oxurion, Palatin, Regeneron, RegenxBio, Retinal Sciences, Retrope, Roivant, Sandoz, Santen, Spark, Stealth Biotherapeutics, Sustained Nano Systems, Takeda, Théa
Quan Dong Nguyen MD, MSc has disclosed the following relevant financial relationships:
Consultant - Bayer, Eyepoint, Genentech, Regeneron, Santen
Contracted Research - Genentech, Gilead, Novartis, Regeneron, Santen
Jonathan Prenner, MD has disclosed the following relevant financial relationships:
Consultant - Alcon, Regeneron
Christina Y. Weng, MD, MBA has disclosed the following relevant financial relationships:
Consultant - Alcon, Alimera Sciences, Novartis, REGENXBIO, Regeneron, Allergan/AbbVie, Dutch Ophthalmic Research Center
Reviewers report the following relationship(s)
Louis Settembrino, CHCP, Catalyst Medical Education, LLC, President and CEO: has no financial relationships to disclose.
Dorothy Caputo, MA, BSN, RN, AKH Lead Nurse Planner/Reviewer: has no financial relationships to disclose.
Patricia Brignoni, AKH Director of Operations/Reviewer: has no financial relationships to disclose.
Unlabeled and Investigational Usage
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH, Inc., Advancing Knowledge in Healthcare specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.
Copyright Statement
Copyright 2020 Catalyst Medical Education, LLC No part of this publication may be produced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical photocopying, recording, or otherwise, without the prior permission of the publisher.
CME Questions?
If you have questions about this activity, please contact AKH Inc. at tbrignoni@akhcme.com.